Jazz Pharmaceuticals (JAZZ) Goodwill (2010 - 2026)

Jazz Pharmaceuticals' Goodwill history runs 17 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Goodwill rose 2.55% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 2.55% YoY), while the FY2025 annual figure was $1.8 billion, up 6.58% from the prior year.
• Goodwill was $1.8 billion for Q1 2026 at Jazz Pharmaceuticals, down from $1.8 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $1.8 billion in Q2 2025 to a low of $1.6 billion in Q3 2022.
• Historically, Goodwill has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2023.
• Biggest YoY gain for Goodwill was 89.95% in 2022; the steepest drop was 13.89% in 2022.
• A 5-year view of Goodwill shows it stood at $1.7 billion in 2022, then gained by 3.57% to $1.8 billion in 2023, then retreated by 2.1% to $1.7 billion in 2024, then rose by 6.58% to $1.8 billion in 2025, then retreated by 1.33% to $1.8 billion in 2026.
• The last three Goodwill figures came in at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.